Navigation Links
Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
Date:9/17/2010

CHAPEL HILL, N.C., Sept. 17 /PRNewswire/ -- For Pfizer, a key success factor in bringing Viagra successfully to market involved effectively naming and clarifying the condition that the drug was designed to treat. In this process, the brand team was able to shift the nomenclature for the condition from "impotence" (with its negative connotations and somewhat judgmental overtone) to "erectile dysfunction" (more clinical-sounding) to "ED" (casual and conversationally appropriate).

Leading biopharma companies have employed similar naming and communication strategies in introducing other first-in-class therapies for new or socially sensitive conditions like benign prostatic hypertrophy, social phobia, PMS, panic attack, insomnia, restless legs, overactive bladder, HIV and fibromyalgia.

A new Best Practices, LLC benchmarking report, Best Practices for Internal Communications Regarding Brands & Disease State, examines how companies communicate at the brand and disease state levels in order to educate employees internally and build a consistent, credible external message surrounding new products. Comprising in-depth surveys of 32 top biopharma companies and a series of executive interviews, this study will enable marketing and brand team leaders to implement the type of well-timed and well-targeted communications strategies essential for cementing both the medical and commercial framework for a new product's market entry and supporting its overall success as a brand.

Key topics covered in this research include:

  • Ten best practices for internal disease state communication excellence
  • Effective communication channels & use of new communication technologies
  • Timing of communication activities by product development phase
  • Advantages & disadvantages of employee message segmentation
  • Tracking internal message effectiveness
  • Preventing sensitive-information leaks
  • Using KOLs to influence employees
  • Special challenges for products treating socially sensitive conditions or diseases, first-in-class products, or new disease states or conditions
  • Needs creation marketing tactics

To learn more about this report, including information about the research participants, key findings and sample best practices, please download a complimentary excerpt and study overview at: http://www3.best-in-class.com/rr1022.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
4. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
5. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
6. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
7. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
8. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
9. Positive Results Published Using AtriCure Minimally Invasive Products
10. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
11. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Serve You Rx Vermont, LLC, a wholly ... You), based in Milwaukee, Wisconsin , has ... in Middlebury, Vermont , from Pharmacy Health ... so it was perfect timing for this opportunity to present ... Serve You. "Like us, NEMOP has a high-touch service model, ...
(Date:3/22/2017)... , Mar 22, 2017 Research ... Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022" ... ... Inhibitors Market & Clinical Pipeline Insight 2022 report gives comprehensive ... and integration of immune check point inhibitors as main streamline ...
(Date:3/22/2017)... , March 22, 2017 ... Manufacturing Organization (CDMO), held a special event to introduce ... in Lexington, Kentucky . The inaugural ... Piramal Group Chairman Ajay Piramal, and Piramal Pharma ... ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... , ... “The Trainer”: an electrifying and suspenseful gunslinger novel with a ... an active imagination and an enthusiasm for action and adventure stories. , ... Hart, who sat looking at the thirty-three notches that lined the edges of the ...
(Date:3/22/2017)... ... March 22, 2017 , ... Cosmetic Town, an online plastic ... its companion print magazine. The new magazine, scheduled for release in mid-April, includes ... by board-certified doctors from across the country. , According to the senior editor ...
(Date:3/22/2017)... ... 22, 2017 , ... The American Society for Preventive ... form for prescribers to improve patients’ access to the revolutionary therapy for appropriate ... part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues and Recommendations: ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition of Colon Cancer ... focused on cancer patients, cancer centers and advocacy groups, and MJH Studios™, a ... series, “No Ifs, Ands, or Butts,” that focuses on Colorectal Cancer detection, prevention ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the medical ... reports Leslie Norins, MD, PhD. He says investigating this possibility, is important ... virus and in new infections with HIV. , His findings appear on ...
Breaking Medicine News(10 mins):